Introduction
Interactions of endogenous or synthetic ligands with their target molecules on the plasma membrane modulate several biological processes, such as cell proliferation and differentiation. As a consequence, aberrant ligand-receptor interactions can promote several diseases, e.g., cancer or immunological disorders. Thus, most of the clinically-approved drugs target overexpressed and/or mutated cell-surface molecules, or their natural ligands (Bhullar et al., 2018; Insel et al., 2019). In addition, synthetic ligands with precise molecular recognition toward distinct receptors have been used for the targeted delivery of payloads into specific diseased cells (Mitchell et al., 2021). However, the study of how both endogenous and synthetic ligands affect the physiology and spatiotemporal regulation of their target receptors is challenging. This Research Topic provides an overview of multidisciplinary strategies used to study ligand-receptor interactions in different physio-pathological contexts.
Although the ligand-receptor interactions are pivotal to activate an intracellular signal transduction, interactions with additional membrane-associated molecules are often critical for modulating signal strength. The interaction of a cell-surface receptor with secondary effectors in cis (i.e., other receptors or cytosolic proteins anchored to the cell surface) can facilitate receptor-ligand binding or can promote formation of multiprotein complexes that trigger precise signaling cascades. A classic example of this type of interactions is constituted by the Eph receptors (EphA and EphB receptor tyrosine kinases) and their ephrin ligands (ephrin-As and ephrin-Bs). Cecchini and Cornelison provided extensive insights on the molecular interactions of Eph receptors and how distinct interactions with their ephrin ligands and proximal proteins located in cis (on the same cell surface) can precisely modulate several cellular processes such as proliferation and differentiation, adhesion and migration, with emphasis on cancer development and progression, as well as cell sensing of the surrounding environment topography.
During the last decades, progress in structural biology has synergized with innovative computational methods to improve study of receptor dynamics and receptor-ligand interactions (Krishna Deepak et al., 2021). Wang et al. proposed a network pharmacology approach to explore the potential mechanism of Tripterygium wilfordii (TW) in the treatment of diabetic nephropathy (DN). The network pharmacology was first proposed by Hopkins et al. (Hopkins 2008) to overcome the so-called “one-drug/one-target/one-disease” approach in drug discovery. So far, several authors applied the network pharmacology approach mainly to elucidate the mechanism of action of several Chinese herbal medicine (Bi et al., 2021; Li et al., 2022; Wu et al., 2022). Wang et al. through a network analysis identified a series of potential targets of TW in the treatment of DN. The results were analyzed through GO biological process analysis and KEGG metabolic pathway and verified with molecular docking analysis. This approach allowed identification of a set of 49 targets involved in inflammatory process, oxidative stress insulin resistance, cell apoptosis and renal fibrosis, ultimately highlighting the specific molecular receptor involved in TW activity. Thus far, application of network pharmacology has been mainly applied for studies of Traditional Chinese Medicine. However, this approach and other computational methods have lately gained great attention in the field of ligand-receptor interactions and to study cell-to-cell communication. Indeed, over the past 5 years, computational methods and single-cell technologies have improved our knowledge of cell-specific ligand–receptor patterns in complex tissues, and provided a better understanding of cell communication (Armingol et al., 2021; Noël et al., 2021; Raredon et al., 2022).
The pipeline of drug development can be boosted by computational analysis, but a final validation with biological evidence is needed to move to pre-clinical and clinical settings. Several high-throughput screening (HTS) approaches have been proposed to improve studies of drug-receptor interactions (Yasi et al., 2020). Murphy et al. used molecular biology techniques to engineer Saccharomyces cerevisiae to express the GPCR CXCR4. The authors developed a tailored HTS approach that ultimately demonstrated the ability of the 2-carboxyphenyl phosphate (fosfosal) to bind and activate CXCR4 only in the presence of CXCL12.
Another important aspect of ligand-receptor interactions is to precisely define interaction dynamics. Radioligand binding assays, surface plasmon resonance analysis, and isothermal calorimetry are great tools to elucidate ligand binding, but they might not be sufficient to determine all receptor states, and often work in a cell-free system using recombinant proteins or peptide domains. On the other hand, atomic force microscopy and other high-resolution imaging techniques, such as transmission electron microscopy, only report static images (Lam et al., 2020). Single-molecule fluorescence imaging overcomes these limitations and can be used to investigate the dynamics and kinetics of different ligand-receptor interactions on live cells (Fernandes et al., 2021). Advanced fluorescence microscopy approaches have revolutionized the possibility to detect and quantify biomolecule complexes and receptors in dynamic cellular systems (Koldsø and Sansom, 2015; Sezgin, 2017). For instance, single-molecule imaging has defined how receptors are activated by their ligands, and how aberrant spatial distribution of membrane receptors is implicated in several pathologies, including nearly all types of cancer (Du and Lovly, 2018). With the advances of microscopy methods, new labeling approaches have emerged to enable precise coupling of fluorescently tags to cell-surface receptors (Wolf et al., 2021). Despite advancing the precision of labeling and visualization of membrane molecules, unfortunately certain fluorolabeling strategies can alter the native spatiotemporal regulation of the tagged receptors (Bosch et al., 2014; Hughes et al., 2014). Thus, the use of appropriate fluorolabeling strategies is pivotal to accurately elucidate receptor motion and localization on the cell surfaces in their native context, without altering physiological functions. In this respect, Amodeo et al. addressed receptor labeling limitations, with emphasis on fluorolabeling methods for live-cell imaging. This paper performed a systematic analysis to guide the chemical biology community in choosing proper fluorophores and methodologies to quantitatively define fluorolabeling efficiency and behavior of chemical tags coupled to membrane receptors in high sensitivity microscopy setups.
To date, several methodological approaches have been developed to better elucidate all aspects of ligand-receptor interactions. However, this research field is growing, and the limitations of different techniques will certainly prompt the development of new strategies that will improve our understanding of ligand-receptor interactions at the molecular level.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Acknowledgments
The Research Topic Editors thank all the authors for their pivotal contributions and the reviewers for their helpful support.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
ArmingolE.OfficerA.HarismendyO.LewisN. E. (2021). Deciphering Cell-Cell Interactions and Communication from Gene Expression. Nat. Rev. Genet.22, 71–88. 10.1038/s41576-020-00292-x
2
BhullarK. S.LagarónN. O.McGowanE. M.ParmarI.JhaA.HubbardB. P.et al (2018). Kinase-targeted Cancer Therapies: Progress, Challenges and Future Directions. Mol. Cancer17, 48. 10.1186/s12943-018-0804-2
3
BiS.XuL.ChenS.BuS.XuY. (2021). Detection of Herbal Combinations and Pharmacological Mechanisms of Clinical Prescriptions for Coronary Heart Disease Using Data Mining and Network Pharmacology. Evidence-Based Complementary Altern. Med.2021, 1–20. 10.1155/2021/9234984
4
BoschP. J.CorrêaI. R.JrSonntagM. H.IbachJ.BrunsveldL.KangerJ. S.et al (2014). Evaluation of Fluorophores to Label SNAP-Tag Fused Proteins for Multicolor Single-Molecule Tracking Microscopy in Live Cells. Biophysical J.107, 803–814. 10.1016/j.bpj.2014.06.040
5
DuZ.LovlyC. M. (2018). Mechanisms of Receptor Tyrosine Kinase Activation in Cancer. Mol. Cancer17, 58. 10.1186/s12943-018-0782-4
6
FernandesD. D.NealeC.GomesG.-N. W.LiY.MalikA.PandeyA.et al (2021). Ligand Modulation of the Conformational Dynamics of the A2A Adenosine Receptor Revealed by Single-Molecule Fluorescence. Sci. Rep.11, 5910. 10.1038/s41598-021-84069-0
7
HopkinsA. L. (2008). Network Pharmacology: the Next Paradigm in Drug Discovery. Nat. Chem. Biol.4, 682–690. 10.1038/nchembio.118
8
HughesL. D.RawleR. J.BoxerS. G. (2014). Choose Your Label Wisely: Water-Soluble Fluorophores Often Interact with Lipid Bilayers. PLoS One9, e87649. 10.1371/journal.pone.0087649
9
InselP. A.SriramK.GorrM. W.WileyS. Z.MichkovA.SalmerónC.et al (2019). GPCRomics: An Approach to Discover GPCR Drug Targets. Trends Pharmacol. Sci.40, 378–387. 10.1016/j.tips.2019.04.001
10
KoldsøH.SansomM. S. P. (2015). Organization and Dynamics of Receptor Proteins in a Plasma Membrane. J. Am. Chem. Soc.137, 14694–14704. 10.1021/jacs.5b08048
11
Krishna DeepakR. N. V.VermaR. K.HartonoY. D.YewW. S.FanH. (2021). Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery. Pharmaceuticals15, 12. 10.3390/ph15010012
12
LamK.-T.TaylorE. L.ThompsonA. J.RueppM.-D.LochnerM.MartinezM. J.et al (2020). Direct Measurement of Single-Molecule Ligand-Receptor Interactions. J. Phys. Chem. B124, 7791–7802. 10.1021/acs.jpcb.0c05474
13
LiX.WeiS.NiuS.MaX.LiH.JingM.et al (2022). Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Mechanism of Huanglian Jiedu Decoction against Sepsis. Comput. Biol. Med.144, 105389. 10.1016/j.compbiomed.2022.105389
14
MitchellM. J.BillingsleyM. M.HaleyR. M.WechslerM. E.PeppasN. A.LangerR. (2021). Engineering Precision Nanoparticles for Drug Delivery. Nat. Rev. Drug Discov.20, 101–124. 10.1038/s41573-020-0090-8
15
NoëlF.Massenet-RegadL.Carmi-LevyI.CappuccioA.GrandclaudonM.TrichotC.et al (2021). Dissection of Intercellular Communication Using the Transcriptome-Based Framework ICELLNET. Nat. Commun.12, 1089. 10.1038/s41467-021-21244-x
16
RaredonM. S. B.YangJ.GarritanoJ.WangM.KushnirD.SchuppJ. C.et al (2022). Computation and Visualization of Cell-Cell Signaling Topologies in Single-Cell Systems Data Using Connectome. Sci. Rep.12, 4187. 10.1038/s41598-022-07959-x
17
SezginE. (2017). Super-resolution Optical Microscopy for Studying Membrane Structure and Dynamics. J. Phys. Condens. Matter29, 273001. 10.1088/1361-648X/aa7185
18
WolfP.GavinsG.Beck‐SickingerA. G.SeitzO. (2021). Strategies for Site‐Specific Labeling of Receptor Proteins on the Surfaces of Living Cells by Using Genetically Encoded Peptide Tags. Chembiochem22, 1717–1732. 10.1002/cbic.202000797
19
WuY.ZhuY.XieN.WangH.WangF.ZhouJ.et al (2022). A Network Pharmacology Approach to Explore Active Compounds and Pharmacological Mechanisms of a Patented Chinese Herbal Medicine in the Treatment of Endometriosis. PLoS One17, e0263614. 10.1371/journal.pone.0263614
20
YasiE. A.KruyerN. S.Peralta-YahyaP. (2020). Advances in G Protein-Coupled Receptor High-Throughput Screening. Curr. Opin. Biotechnol.64, 210–217. 10.1016/j.copbio.2020.06.004
Summary
Keywords
ligand-receptor interactions, membrane receptor, CXCR4, receptor fluorolabeling, co-receptor
Citation
Marchetti L, Porciani D, Mitola S and Giacomelli C (2022) Editorial: Molecular Insights Into Ligand-Receptor Interactions on the Cell Surface. Front. Mol. Biosci. 9:921677. doi: 10.3389/fmolb.2022.921677
Received
16 April 2022
Accepted
28 April 2022
Published
13 May 2022
Volume
9 - 2022
Edited by
William C. Cho, QEH, Hong Kong SAR, China
Reviewed by
Yinghao Wu, Albert Einstein College of Medicine, United States
Updates
Copyright
© 2022 Marchetti, Porciani, Mitola and Giacomelli.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chiara Giacomelli, chiara.giacomelli@unipi.it
This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.